Woerner Stefan M, Benner Axel, Sutter Christian, Schiller Marian, Yuan Yan P, Keller Gisela, Bork Peer, Doeberitz Magnus von Knebel, Gebert Johannes F
Department of Molecular Pathology, Institute of Patholofy, University of Heidelberg, Heidelberg, Germany.
Oncogene. 2003 Apr 17;22(15):2226-35. doi: 10.1038/sj.onc.1206421.
DNA mismatch repair deficiency is observed in about 15% of human colorectal, gastric, and endometrial tumors and in lower frequencies in a minority of other tumors thereby causing insertion/deletion mutations at short repetitive sequences, recognized as microsatellite instability (MSI). Evolution of tumors, including those with MSI, is a continuous process of mutation and selection favoring neoplastic growth. Mutations in microsatellite-bearing genes that promote tumor cell growth in general (Real Common Target genes) are assumed to be the driving force during MSI carcinogenesis. Thus, microsatellite mutations in these genes should occur more frequently than mutations in microsatellite genes without contribution to malignancy (ByStander genes). So far, only a few Real Common Target genes have been identified by functional studies. Thus, comprehensive analysis of microsatellite mutations will provide important clues to the understanding of MSI-driven carcinogenesis. Here, we evaluated published mutation frequencies on 194 repeat tracts in 137 genes in MSI-H colorectal, endometrial, and gastric carcinomas and propose a statistical model that aims to identify Real Common Target genes. According to our model nine genes including BAX and TGFbetaRII were identified as Real Common Targets in colorectal cancer, one gene in gastric cancer, and three genes in endometrial cancer. Microsatellite mutations in five additional genes seem to be counterselected in gastrointestinal tumors. Overall, the general applicability, the capacity to unlimited data analysis, the inclusion of mutation data generated by different groups on different sets of tumors make this model a useful tool for predicting Real Common Target genes with specificity for MSI-H tumors of different organs, guiding subsequent functional studies to the most likely targets among numerous microsatellite harboring genes.
在约15%的人类结直肠癌、胃癌和子宫内膜癌中观察到DNA错配修复缺陷,在少数其他肿瘤中的发生率较低,从而导致短重复序列处的插入/缺失突变,即微卫星不稳定性(MSI)。肿瘤的演变,包括那些具有MSI的肿瘤,是一个有利于肿瘤生长的突变和选择的连续过程。一般来说,促进肿瘤细胞生长的含微卫星基因中的突变(真正的共同靶基因)被认为是MSI致癌过程中的驱动力。因此,这些基因中的微卫星突变应该比那些对恶性肿瘤无贡献的微卫星基因(旁观者基因)中的突变更频繁地发生。到目前为止,通过功能研究仅鉴定出少数真正的共同靶基因。因此,对微卫星突变的全面分析将为理解MSI驱动的致癌作用提供重要线索。在这里,我们评估了MSI-H结直肠癌、子宫内膜癌和胃癌中137个基因的194个重复序列上已发表的突变频率,并提出了一个旨在识别真正共同靶基因的统计模型。根据我们的模型,包括BAX和TGFbetaRII在内的9个基因被鉴定为结直肠癌中的真正共同靶点,1个基因在胃癌中,3个基因在子宫内膜癌中。另外5个基因中的微卫星突变似乎在胃肠道肿瘤中被反向选择。总体而言,该模型的普遍适用性、无限数据分析能力、纳入不同组在不同肿瘤集上产生的突变数据,使其成为预测不同器官MSI-H肿瘤特异性真正共同靶基因的有用工具,可以指导后续功能研究针对众多含微卫星基因中最可能的靶点。